Opinion: Latent Value in the Literature

With scientific budgets eroding, the biomedical community needs to get more return from the data it has already generated.

Written byRamon Felciano
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, JOHN MARTINEZ PAVLIGAIn the United States, like so many countries around the world, scientists are learning to get by on shoestring budgets. Reduced federal funding has the biomedical community looking for ways to squeeze more out of every grant. In an age of austerity, success is about how smart we are with each dollar invested in the country’s research enterprise.

One way to eke more value from those research and development dollars is to extract more knowledge from the scientific data and findings we have already generated. Decades of investment have produced a wealth of information from basic research projects, translational studies, and clinical trials. But we as a community often do not know what is available, and we lack a coherent resource that brings all of this information together—a massive repository that can be queried, or a powerful tool that can gather intelligence from a number of studies at once.

Recent efforts within the open access community are making inroads toward improving access to data and publications, but there remains a general lack of awareness of the existence of relevant data, as well as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies